Literature DB >> 12759304

More on anticardiolipin and anti-beta2 glycoprotein I in systemic sclerosis.

C M Antonioli, E Danieli, P Airò, R Cattaneo, A Tincani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12759304      PMCID： PMC1754560          DOI： 10.1136/ard.62.6.589

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

1.  Systemic sclerosis sine scleroderma associated with antiphospholipid syndrome.

Authors:  Pollyanna d'Ávila Leite; Jozélio Freire de Carvalho
Journal:  Rheumatol Int       Date:  2010-04-09       Impact factor: 2.631

2.  [Critical limb ischemia in systemic sclerosis].

Authors:  M O Becker; G Riemekasten
Journal:  Z Rheumatol       Date:  2012-06       Impact factor: 1.372

Review 3.  Autoantibodies in systemic sclerosis (scleroderma): clues for clinical evaluation, prognosis and pathogenesis.

Authors:  Alfred Grassegger; Gabriela Pohla-Gubo; Margret Frauscher; Helmut Hintner
Journal:  Wien Med Wochenschr       Date:  2008

4.  Clinical significance of antiphospholipid antibodies in Indian scleroderma patients.

Authors:  R Gupta; M M Thabah; S Gupta; S Shankar; A Kumar
Journal:  Rheumatol Int       Date:  2009-12       Impact factor: 2.631

5.  Independent association of anti-beta(2)-glycoprotein I antibodies with macrovascular disease and mortality in scleroderma patients.

Authors:  Francesco Boin; Stefano Franchini; Elizabeth Colantuoni; Antony Rosen; Fredrick M Wigley; Livia Casciola-Rosen
Journal:  Arthritis Rheum       Date:  2009-08

Review 6.  Antibodies in scleroderma: direct pathogenicity and phenotypic associations.

Authors:  Lorinda Chung; Paul J Utz
Journal:  Curr Rheumatol Rep       Date:  2004-04       Impact factor: 4.592

7.  Prevalence and Clinical Associations of Antiphospholipid Antibodies in Systemic Sclerosis: New Data From a French Cross-Sectional Study, Systematic Review, and Meta-Analysis.

Authors:  Vincent Sobanski; Angélique Lemaire-Olivier; Jonathan Giovannelli; Luc Dauchet; Myriam Simon; Benjamin Lopez; Cécile Yelnik; Marc Lambert; Pierre-Yves Hatron; Eric Hachulla; Sylvain Dubucquoi; David Launay
Journal:  Front Immunol       Date:  2018-11-02       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.